Patents by Inventor Elyse A. WATKINS

Elyse A. WATKINS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-INFLAMMATORY CYTOKINES AND METHODS OF USE
    Publication number: 20240052006
    Abstract: Aspects of the present disclosure provide methods and compositions for treatment of autoimmune disorders including, for example, multiple sclerosis and rheumatoid arthritis. Also disclosed are methods for promoting wound healing. Certain aspects are directed to antiinflammatory cytokines operatively linked to an albumin protein. Further aspects relate to methods for delivering an anti-inflammatory cytokine to a lymph node.
    Type: Application
    Filed: September 24, 2021
    Publication date: February 15, 2024
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventors: Jeffrey A HUBBELL, Eiji YUBA, Elyse WATKINS, Jun ISHIHARA, Ako ISHIHARA, Erica BUDINA, Abigail LAUTERBACH
  • TARGETED, INTRACELLULAR DELIVERY OF THERAPEUTIC PEPTIDES USING SUPRAMOLECULAR NANOMATERIALS
    Publication number: 20240033373
    Abstract: Provided herein are nanoparticles to encapsulate therapeutic agents and methods of use thereof for intracellular delivery and disease treatment. In particular, the present disclosure provides polymersomes for use in the delivery of therapeutic agents, e.g. stapled peptides, to diseased (e.g. cancer) cells.
    Type: Application
    Filed: August 31, 2021
    Publication date: February 1, 2024
    Inventors: Matthew Tirrell, James L. Labelle, Mathew Schnorenberg, Jeffrey A. Hubbell, Elyse A. Watkins
  • METHODS AND COMPOSITIONS FOR TARGETING LIVER AND LYMPH NODE SINUSOIDAL ENDOTHELIAL CELL C-TYPE LECTIN (LSECTIN)
    Publication number: 20210171642
    Abstract: Certain embodiments are directed to compositions and methods for targeting an antigen to a liver and lymph node C type lectin (LSECtin). In particular aspects the compositions disclosed herein can induce tolerogenic immunity to the targeted antigen.
    Type: Application
    Filed: March 26, 2019
    Publication date: June 10, 2021
    Applicant: The University of Chicago
    Inventors: Jeffrey HUBBELL, Elyse A. WATKINS, Tomasz SLEZAK